Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy (Q24187043)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy	scientific article

Statements

scholarly article

0 references

Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy (English)

0 references

0 references

3

0 references

0 references

2

0 references

4

0 references

5

object named as

Oliver Blank

0 references

Jörg Janne Vehreschild

6

object named as

Jörg-Janne Vehreschild

0 references

publication date

21 December 2015

0 references

Cochrane Database of Systematic Reviews

0 references

A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase 3, Randomized, Placebo-controlled Trial of Filgrastim in Patients with Haematological Malignancies Undergoing Matched-related Allogeneic Bone Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of the value of treatment with granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a randomized clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised study of prophylactic G-CSF following MRC UKALL XI intensification regimen in childhood ALL and T-NHL

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of Filgrastim schedule variation on hematopoietic recovery post-chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

G-CSF versus GM-CSF for stimulation of peripheral blood progenitor cells (PBPC) and leukocytes in healthy volunteers: comparison of efficacy and tolerability

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superinfections by Escherichia coli resistant to fluoroquinolones in immunocompromised patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the efficacy of prophylactic intravenous antibiotherapy with ceftriaxone in post-chemotherapy agranulocytic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic first-line antibiotics reduce infectious fever and shorten hospital stay during chemotherapy-induced agranulocytosis in childhood acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal timing of G-CSF administration after CD34 immunoselected peripheral blood progenitor cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practical methods for incorporating summary time-to-event data into meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as Adjunct Therapy in Relapsed Hodgkin Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma--results of a prospective multicentre controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

G-CSF administered in time-sequenced setting during remission induction and consolidation therapy of adult acute lymphoblastic leukemia has beneficial influence on early recovery and possibly improves long-term outcome: a randomized multicenter stud

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of bacterial and fungal infections in acute leukemia patients: a new and potent combination of oral norfloxacin and amphotericin B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: a randomized phase 2 trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biology of GM-CSF: regulation of production and interaction with its receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myélobla

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil recovery in elderly breast cancer patients receiving adjuvant anthracycline-containing chemotherapy with pegfilgrastim support.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of recombinant human granulocyte-macrophage colony-stimulating factor to children undergoing allogeneic marrow transplantation: a prospective, randomized, double-masked, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fever in immunocompromised patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoprophylaxis with ciprofloxacin in ovarian cancer patients receiving paclitaxel: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infection in cancer patients. A continuing association

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized study of clinical and economic consequences of using G-CSF following autologous peripheral blood progenitor cell (PBPC) transplantation in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923).

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human Granulocyte Colony-Stimulating Factor in Children With High-Risk Acute Lymphoblastic Leukemia: A Children’s Cancer Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy-evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Onc

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26687844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

1 reference

https://api.crossref.org/works/10.1002/14651858.CD007107.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD007107.PUB3

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24187043&oldid=1742034200"